Trial intelligence / Profile preview

Ambroxol Lozenge for Sore Throat in Acute Viral Pharyngitis

NCT00148499Phase 3Completed

Sponsor
Boehringer Ingelheim
Start
Oct 2005
Primary completion
Jun 2006
Modality
Small Molecules
Countries
2
01

Overview

A Phase 3 trial of ambroxol in acute viral pharyngitis, sponsored by Boehringer Ingelheim. Started Oct 2005; status: completed.

02

Drugs

ambroxol
03

Conditions

acute viral pharyngitis

Beyond the preview

Go deeper on NCT00148499.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00148499.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call